查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1992930

Erucamide市场：2026-2032年全球市场按产品类型、技术、应用和最终用途行业分類的预测

Erucamide Market by Product Type, Technology, Application, End Use Industry - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年， Erucamide市场价值将达到 2.8658 亿美元，到 2026 年将成长至 2.9962 亿美元，到 2032 年将达到 3.8539 亿美元，复合年增长率为 4.32%。

主要市场统计数据
基准年 2025 2.8658亿美元
预计年份：2026年 2.9962亿美元
预测年份 2032 3.8539亿美元
复合年增长率 (%) 4.32%

对Erucamide的化学性质、工业应用、加工注意事项以及知情决策者所需的实用框架进行了简明扼要的基础性说明。

Erucamide已成为聚合物、润滑剂和表面改质剂领域中至关重要的润滑剂和加工助剂，并广泛应用于整体製造业。本执行摘要概述了Erucamide在现代生产环境中的作用，重点介绍了其理化性质、与聚烯的相容性以及在改善表面触感、摩擦性能和加工稳定性方面的效用。读者将清楚了解Erucamide在价值链中的定位、它如何与常用树脂系统相互作用，以及为何材料工程师和采购负责人越来越关注其规格和采购。

原材料来源的演变、永续发展优先事项、监管变化以及加工技术的创新如何重新定义Erucamide的用途和供应链策略。

随着原料采购管道、永续发展优先事项以及下游製程配方偏好的同步演变，Erucamide）的市场格局正在迅速变化。在整个价值链中，筹资策略都在不断调整，以应对日益严格的原材料价格波动和生命週期影响监测，这迫使配方生产商重新评估添加剂的性能标准，并要求供应商提高可追溯性。加工技术和混炼技术的进步拓展了Erucamide的有效应用范围，使其不再局限于传统的润滑剂应用，从而在低温下实现了更佳的迁移控制，并增强了其与先进聚烯共混物的相容性。

2025 年美国关税调整将如何影响整个添加剂供应链的采购行为、供应商多元化和库存策略？

2025年美国关税调整对筹资策略、供应商选择和供应链紧急时应对计画产生了实际的影响。进口关税改变了出口商的收货成本差异，并将采购讨论的重点转向国内生产的韧性和供应商网路的多元化。因此，买家重新评估了与供应商的长期合作关係，并加快了二级资讯认证流程，以确保供应的连续性。

可操作的细分资讯揭示了应用、最终用途行业、产品类型和生产技术如何决定Erucamide的适用性和供应商选择。

细分市场分析揭示了影响依Erucamide选择和配方策略的特定应用因素和技术要求。根据应用领域，电缆和电线、挤出成型、射出成型和包装薄膜的市场动态各不相同。包装薄膜尤其需要关注，因为它们又细分为双轴延伸聚丙烯(BOPP)、高密度聚苯乙烯(HDPE) 和低密度聚乙烯 (LDPE)，每种材料对迁移和透明度都有不同的限制。在电缆和电线应用中，电气相容性和热稳定性是优先考虑的因素；而在挤出成型和射出成型中，加工窗口容差和母粒系统的均质性则至关重要。

区域比较分析重点阐述了美洲、欧洲、中东和非洲以及亚太地区的趋势如何影响供应可靠性、合规预期和商业策略。

区域趋势决定了供应链结构、监管摩擦以及製造商和买家必须应对的竞争强度。在美洲，由于接近性主要的聚合物加工商，且高度重视近岸采购，因此对稳定的供应模式和可预测的物流的需求日益增长。该地区的生产商通常优先考虑卡车直达工厂的配送模式以及支援准时生产和快速配方调整的供应商伙伴关係。

与推动Erucamide整个供应链可靠性、技术差异化和快速认证的公司建立竞争性和策略性伙伴关係。

Erucamide价值链中的主要企业拥有卓越的技术、柔软性的供应链以及对品质保证的坚定承诺。投资于先进蒸馏和加氢等炼油技术的市场参与企业，能够持续实现高价值应用所需的更严格的杂质控制和可重复的产品规格。同样重要的是，那些已建立多模态物流和区域仓储的企业，这使它们能够更快地应对需求波动和关税相关的干扰。

为製造商和买家提供切实可行的优先策略措施，以增强供应韧性、加快产品客製化进程，并在高度波动的贸易环境中保护利润率。

产业领导者应优先采取一系列切实可行的措施来增强韧性并创造商业性优势。首先，供应商分布应多元化，以平衡成本、地理风险和品质稳定性。关键等级产品的双重采购以及对区域供应商进行认证可以减少单点故障。其次，投资于能够加速产品客製化并促进与加工商共同开发的技术伙伴关係。这将缩短新配方的上市时间，并实现针对性能目标的快速迭代改进。

采用严谨的混合方法研究途径，结合专家访谈、技术文献回顾与供应链映射，检验Erucamide的绩效与商业性趋势。

本分析的调查方法结合了定性专家访谈、技术文献综述和供应链图谱分析，以全面观点Erucamide的发展趋势。研究重点包括与配料负责人、采购经理、製程工程师和物流专家进行讨论，以了解实际的限制因素和应用标准。基于这些对话，研究人员对生产技术、操作特性和特定应用性能要求进行了系统评估。

对Erucamide在绩效、合规性和供应链韧性方面的策略角色进行综合分析，凸显了跨职能决策的必要性。

Erucamide在聚合物添加剂产品组合中占据着至关重要的地位，它完美地融合了材料性能、加工性能和法规遵从性。从整体情况来看，该材料的效用涵盖多个工业领域，每个领域都面临独特的技术和商业性压力，这些压力会影响产品设计和采购选择。相关人员使其配方策略与不断变化的法规预期保持一致，并投资于多元化的采购和技术进步，就能更清楚地实现商业性稳定性和产品差异化。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章： Erucamide市场：依产品类型划分

  • 颗粒
  • 液体
  • 颗粒
  • 粉末

第九章： Erucamide市场：依技术划分

  • 蒸馏
  • 氢化
  • 溶剂萃取

第十章： Erucamide市场：依应用领域划分

  • 电线电缆
  • 挤压
  • 射出成型
  • 包装膜
    • 双轴延伸聚丙烯
    • 高密度聚苯乙烯
    • 低密度聚乙烯

第十一章： Erucamide市场：以最终用途产业划分

  • 车
  • 建造
  • 电子与电机工程
  • 鞋类和皮革
  • 包装
    • 软包装
    • 工业包装
    • 硬包装

第十二章： Erucamide市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十三章： Erucamide市场：依集团划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十四章Erucamide市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十五章：美国Erucamide市场

第十六章：中国Erucamide市场

第十七章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Aceto Corporation
  • Arkema SA
  • Biosynth AG
  • Cayman Chemical Company
  • Clearsynth Labs Ltd.
  • Croda International Plc
  • GSA Chemical Corporation
  • Haihang Industry Co., Ltd.
  • Hangzhou DayangChem Co., Ltd.
  • High Grade Industries India Private Limited
  • Hunan Er-Kang Pharmaceutical Co., Ltd.
  • Jiangxi Hongyuan Chemical Co., Ltd.
  • Merck KGaA
  • Nippon Fine Chemical Co., Ltd.
  • Oleon NV
  • Parchem Fine & Specialty Chemicals, Inc.
  • PMC Biogenix, Inc.
  • Santa Cruz Biotechnology, Inc.
  • Shandong Chuangxin Biotechnology Co., Ltd.
  • Sigma-Aldrich Chemicals Private Limited
  • Spectrum Chemical Mfg. Corp.
  • Tokyo Chemical Industry Co., Ltd.
  • Zhejiang Wumei Biotechnology Co., Ltd.
Product Code: MRR-1A1A064C0127

The Erucamide Market was valued at USD 286.58 million in 2025 and is projected to grow to USD 299.62 million in 2026, with a CAGR of 4.32%, reaching USD 385.39 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 286.58 million
Estimated Year [2026] USD 299.62 million
Forecast Year [2032] USD 385.39 million
CAGR (%) 4.32%

Concise foundational orientation to erucamide chemistry, industrial utility, processing considerations, and the practical framework decision-makers need for informed actions

Erucamide has emerged as a pivotal slip agent and processing aid in polymers, lubricants, and surface modifiers, with broad relevance across manufacturing verticals. This executive summary frames erucamide's role within contemporary production environments, emphasizing its physicochemical attributes, compatibility with polyolefins, and utility in enhancing surface feel, frictional properties, and processing stability. Readers will gain a clear sense of where erucamide integrates into value chains, how it interacts with typical resin systems, and why material engineers and procurement professionals increasingly focus on its specification and sourcing.

The following content synthesizes technical characteristics with practical considerations for industrial adoption. It bridges laboratory performance with industrial-scale requirements, highlighting manufacturing variables such as melt flow behavior, additive migration, and thermal stability under common processing regimes. The intent is to orient decision-makers to the product's practical benefits and constraints, while setting a shared vocabulary for subsequent sections that address regulatory adjustments, trade environments, segmentation complexity, regional dynamics, and corporate strategies.

How evolving feedstock sources, sustainability priorities, regulatory shifts, and processing innovations are redefining erucamide applications and supply chain strategies

The erucamide landscape is shifting rapidly as raw material pathways, sustainability priorities, and downstream formulation preferences evolve in parallel. Across the value chain, sourcing strategies are adapting to feedstock volatility and increased scrutiny over lifecycle impacts, pushing formulators to reassess additive performance criteria and suppliers to enhance traceability. Advances in processing technologies and compounding approaches have expanded the effective use cases for erucamide beyond traditional slip applications, enabling improved low-temperature migration control and compatibility with advanced polyolefin blends.

Concurrently, regulatory and commercial pressures are accelerating the pursuit of greener chemistries and alternative supply networks. Brand owners are integrating additive-level transparency into their sustainability narratives, which in turn prompts processors to secure verifiable supply chains and consider secondary parameters such as biodegradability profiles and renewable feedstock sourcing. These forces intersect with technological innovation: enhanced distillation and hydrogenation routes alongside solvent extraction refinements have raised the bar for consistency and impurity control, which supports higher-value applications and longer product lifecycles. Together, these shifts are redefining how erucamide is specified, procured, and positioned within product portfolios.

How the 2025 United States tariff adjustments reshaped procurement behavior, supplier diversification, and inventory strategies across additive supply chains

United States tariff adjustments in 2025 created tangible ripple effects across sourcing strategies, supplier selection, and supply chain contingency planning. Import duties altered relative landed cost differentials for exporters and redirected procurement conversations toward domestic production resilience and diversified supplier networks. As a direct consequence, buyers reassessed long-standing supplier relationships and accelerated qualification timelines for secondary sources to preserve continuity of supply.

These tariff-driven dynamics also stimulated deeper collaboration between buyers and manufacturers to redesign procurement contracts with clauses that address duty pass-through, inventory staging, and shared risk for supply interruptions. Logistics planners adjusted inbound routing and inventory positions to reduce exposure to ports and customs treatments that incurred higher duty liabilities. At the same time, manufacturers prioritized near-shoring and investment in local compounding capabilities to minimize import dependency for critical additive volumes. The net effect emphasized operational agility: organizations that integrated tariff scenario planning into sourcing playbooks and stress-tested supplier capacity performed better in maintaining production schedules, while those reliant on a narrow set of foreign suppliers faced more acute short-term disruptions.

Actionable segmentation intelligence revealing how application, end-use industry, product type, and production technology determine erucamide suitability and supplier selection

Segmentation insights illuminate application-specific drivers and technical requirements that influence erucamide selection and formulation tactics. Based on Application, market dynamics vary between Cable & Wire, Extrusion, Injection Molding, and Packaging Films, with the latter category demanding particular attention because Packaging Films subdivide into Biaxial Oriented Polypropylene, High Density Polyethylene, and Low Density Polyethylene, each imposing distinct migration and clarity constraints. Cable & Wire applications prioritize electrical compatibility and thermal stability, whereas extrusion and injection molding emphasize processing window resilience and homogenization in masterbatch systems.

When viewed through the lens of End Use Industry, sectoral priorities further refine product specifications. Automotive applications demand thermal endurance and low-bleed profiles to maintain aesthetic and functional surfaces, while Construction markets value durability and weathering resistance. Electronics & Electrical segments require additive purity to avoid interference with sensitive components, and Footwear & Leather leverage slip and feel improvements to enhance consumer perception. The Packaging vertical, which is analyzed as Flexible Packaging, Industrial Packaging, and Rigid Packaging, places a premium on clarity, anti-blocking performance, and regulatory compliance for food contact when relevant.

Product Type segmentation clarifies handling, formulation, and dosing considerations. Granule, Liquid, Pellet, and Powder forms present distinct advantages and constraints for dosing accuracy, dispersion efficiency, and worker safety. Liquid formats facilitate rapid blending but necessitate solvent management, while granules and pellets typically offer easier handling and consistent dosing in automated compounding lines. Powder forms require enhanced dust control and dispersion technologies to achieve uniform additive distribution.

Technology choices govern production cost profile and impurity control. Distillation routes excel at delivering narrow boiling point fractions and therefore support higher-purity grades, Hydrogenation pathways reduce unsaturation-related instability and can improve color and odor profiles, and Solvent Extraction techniques offer selective removal of undesired constituents. Each technological approach yields trade-offs between capital intensity, environmental footprint, and achievable product performance, shaping supplier capabilities and the technical fit for end-use requirements.

Comparative regional analysis highlighting how Americas, Europe Middle East & Africa, and Asia-Pacific dynamics influence supply reliability, compliance expectations, and commercial strategies

Regional dynamics dictate supply chain architecture, regulatory friction, and the competitive intensity that manufacturers and buyers must navigate. In the Americas, proximity to major polymer converters and a pronounced focus on near-shore sourcing drive demand for consistent supply profiles and logistics predictability. Producers in this region often emphasize truck-to-plant distribution models and supplier partnerships that support just-in-time manufacturing and rapid formulation changes.

Europe, Middle East & Africa present a diverse regulatory and market landscape where sustainability mandates and stringent product stewardship expectations shape purchasing behavior. Chemical regulations and extended producer responsibility frameworks encourage producers to highlight traceability and impurity control. In these markets, local compliance, certifications, and demonstrated lifecycle assessments play a larger role in procurement qualification than in some other regions.

Asia-Pacific encompasses varied production bases and a dense concentration of polymer processing capacity, which sustains a broad set of erucamide application opportunities. Manufacturing hubs within this region frequently leverage integrated supply chains that offer scale advantages, while regional demand exhibits rapid responsiveness to changes in consumer packaging trends and industrial expansion. Across all regions, cross-border logistics complexity, lead-time sensitivity, and differing regulatory thresholds converge to influence supplier selection and risk management strategies.

Competitive company attributes and strategic partnerships that drive reliability, technical differentiation, and faster qualification across the erucamide supply chain

Leading companies in the erucamide value chain exhibit a combination of technical excellence, supply chain flexibility, and a clear posture on quality assurance. Market participants that invest in refining technology, such as advanced distillation and hydrogenation capabilities, consistently achieve tighter impurity controls and more reproducible product specifications that appeal to high-value applications. Equally important, firms that establish multi-modal logistics options and regional warehousing can respond more rapidly to shifts in demand or tariff-related disruptions.

Strategic partnerships between additive producers and resin converters or compounders strengthen route-to-market effectiveness and shorten qualification cycles for end-users. Companies that offer formulation support, application testing, and co-development services differentiate themselves by reducing the integration friction for processors. Transparency around batch traceability, certificates of analysis, and adherence to relevant regulatory frameworks further enhances supplier credibility, especially when brand owners require verifiable supply chain information for sustainability reporting and compliance audits.

Practical and prioritized strategic moves for manufacturers and buyers to build supply resilience, accelerate product customization, and protect margins in a dynamic trade environment

Industry leaders should prioritize a set of actionable moves that enhance resilience and create commercial advantage. First, diversify supplier footprints to balance cost, geographic exposure, and quality consistency; dual-sourcing critical grades and qualifying regional suppliers reduces single-point failures. Second, invest in technical partnerships that accelerate product customization and co-development with converters, thereby shortening time-to-market for new formulations and enabling rapid iteration on performance targets.

Third, embed tariff and trade scenario planning into procurement playbooks to ensure pricing and logistics strategies remain adaptable. This involves establishing inventory buffers at strategic nodes, negotiating flexible contract terms with suppliers, and exploring bonded or free-trade arrangements where appropriate. Fourth, elevate documentation and traceability practices to support regulatory compliance and sustainability narratives; clear certificates of analysis, material origin data, and process transparency strengthen customer trust and facilitate market access in stricter regulatory environments. Finally, pursue targeted capital investment in refining and purification technologies to improve grade consistency and enable movement into higher-margin applications that demand low impurity and stable migration behavior.

Rigorous mixed-method research approach integrating expert interviews, technical literature review, and supply chain mapping to validate erucamide performance and commercial dynamics

The research methodology underpinning this analysis combined qualitative expert interviews, technical literature review, and supply chain mapping to generate a comprehensive perspective on erucamide dynamics. Primary engagements included discussions with formulators, procurement leads, process engineers, and logistics specialists to capture real-world constraints and adoption criteria. These conversations informed a structured assessment of production technologies, handling characteristics, and application-specific performance requirements.

Secondary research consolidated publicly available technical papers, regulatory documents, and patent filings to validate observed trends and identify technological maturation in distillation, hydrogenation, and solvent extraction processes. Supply chain mapping integrated customs data patterns and logistics route analysis to surface sensitivity points related to tariff changes and regional lead times. Throughout, analytical rigor focused on triangulating evidence across sources to ensure the conclusions reflect operational realities and not isolated anecdotes.

Synthesis of erucamide's strategic role across performance, compliance, and supply resilience that underscores the need for integrated cross-functional decision-making

Erucamide occupies a critical niche in polymer additive portfolios where material performance, processing behavior, and regulatory compliance intersect. The cumulative picture shows a material whose utility extends across multiple industrial domains, each with distinct technical and commercial pressures that influence product design and sourcing choices. Stakeholders that align formulation strategy with evolving regulatory expectations and invest in diversified sourcing and technological refinement will find clearer pathways to commercial stability and product differentiation.

Looking ahead, the interplay between supply chain resilience, technological advancement, and sustainability commitments will determine which participants capture the most value. Organizations that treat additive strategy as integral to product performance and supply continuity-rather than as a low-touch procurement item-will achieve stronger outcomes in both operational reliability and end-customer satisfaction. This conclusion underscores the importance of cross-functional alignment among R&D, procurement, and commercial teams to translate insight into action.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Erucamide Market, by Product Type

  • 8.1. Granule
  • 8.2. Liquid
  • 8.3. Pellet
  • 8.4. Powder

9. Erucamide Market, by Technology

  • 9.1. Distillation
  • 9.2. Hydrogenation
  • 9.3. Solvent Extraction

10. Erucamide Market, by Application

  • 10.1. Cable & Wire
  • 10.2. Extrusion
  • 10.3. Injection Molding
  • 10.4. Packaging Films
    • 10.4.1. Biaxial Oriented Polypropylene
    • 10.4.2. High Density Polyethylene
    • 10.4.3. Low Density Polyethylene

11. Erucamide Market, by End Use Industry

  • 11.1. Automotive
  • 11.2. Construction
  • 11.3. Electronics & Electrical
  • 11.4. Footwear & Leather
  • 11.5. Packaging
    • 11.5.1. Flexible Packaging
    • 11.5.2. Industrial Packaging
    • 11.5.3. Rigid Packaging

12. Erucamide Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Erucamide Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Erucamide Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Erucamide Market

16. China Erucamide Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Aceto Corporation
  • 17.6. Arkema S.A.
  • 17.7. Biosynth AG
  • 17.8. Cayman Chemical Company
  • 17.9. Clearsynth Labs Ltd.
  • 17.10. Croda International Plc
  • 17.11. GSA Chemical Corporation
  • 17.12. Haihang Industry Co., Ltd.
  • 17.13. Hangzhou DayangChem Co., Ltd.
  • 17.14. High Grade Industries India Private Limited
  • 17.15. Hunan Er-Kang Pharmaceutical Co., Ltd.
  • 17.16. Jiangxi Hongyuan Chemical Co., Ltd.
  • 17.17. Merck KGaA
  • 17.18. Nippon Fine Chemical Co., Ltd.
  • 17.19. Oleon NV
  • 17.20. Parchem Fine & Specialty Chemicals, Inc.
  • 17.21. PMC Biogenix, Inc.
  • 17.22. Santa Cruz Biotechnology, Inc.
  • 17.23. Shandong Chuangxin Biotechnology Co., Ltd.
  • 17.24. Sigma-Aldrich Chemicals Private Limited
  • 17.25. Spectrum Chemical Mfg. Corp.
  • 17.26. Tokyo Chemical Industry Co., Ltd.
  • 17.27. Zhejiang Wumei Biotechnology Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL ERUCAMIDE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL ERUCAMIDE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ERUCAMIDE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL ERUCAMIDE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ERUCAMIDE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ERUCAMIDE MARKET SIZE, BY GRANULE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL ERUCAMIDE MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ERUCAMIDE MARKET SIZE, BY PELLET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL ERUCAMIDE MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL ERUCAMIDE MARKET SIZE, BY DISTILLATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ERUCAMIDE MARKET SIZE, BY HYDROGENATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL ERUCAMIDE MARKET SIZE, BY SOLVENT EXTRACTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL ERUCAMIDE MARKET SIZE, BY CABLE & WIRE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ERUCAMIDE MARKET SIZE, BY EXTRUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL ERUCAMIDE MARKET SIZE, BY INJECTION MOLDING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL ERUCAMIDE MARKET SIZE, BY BIAXIAL ORIENTED POLYPROPYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ERUCAMIDE MARKET SIZE, BY HIGH DENSITY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL ERUCAMIDE MARKET SIZE, BY LOW DENSITY POLYETHYLENE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL ERUCAMIDE MARKET SIZE, BY AUTOMOTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ERUCAMIDE MARKET SIZE, BY CONSTRUCTION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ERUCAMIDE MARKET SIZE, BY ELECTRONICS & ELECTRICAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ERUCAMIDE MARKET SIZE, BY FOOTWEAR & LEATHER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ERUCAMIDE MARKET SIZE, BY FLEXIBLE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ERUCAMIDE MARKET SIZE, BY INDUSTRIAL PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ERUCAMIDE MARKET SIZE, BY RIGID PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ERUCAMIDE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. AMERICAS ERUCAMIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 76. AMERICAS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 77. AMERICAS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 78. AMERICAS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 79. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 80. AMERICAS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 81. AMERICAS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 82. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 84. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 85. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 86. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 87. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 88. NORTH AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 89. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 91. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 92. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 93. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 94. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 95. LATIN AMERICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 96. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 103. EUROPE ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 104. EUROPE ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 105. EUROPE ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 106. EUROPE ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 108. EUROPE ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 109. EUROPE ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 110. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 113. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 114. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 115. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 116. MIDDLE EAST ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 117. AFRICA ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. AFRICA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AFRICA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 120. AFRICA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 121. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 122. AFRICA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 123. AFRICA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ERUCAMIDE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. ASEAN ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. ASEAN ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. ASEAN ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 135. ASEAN ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 137. ASEAN ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 138. ASEAN ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 139. GCC ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GCC ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. GCC ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 142. GCC ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 144. GCC ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 145. GCC ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPEAN UNION ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 153. BRICS ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. BRICS ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. BRICS ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 156. BRICS ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 158. BRICS ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 159. BRICS ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 160. G7 ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 161. G7 ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. G7 ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 163. G7 ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 164. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 165. G7 ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 166. G7 ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 167. NATO ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. NATO ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. NATO ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 170. NATO ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 172. NATO ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 173. NATO ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL ERUCAMIDE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. UNITED STATES ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 176. UNITED STATES ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. UNITED STATES ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 178. UNITED STATES ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 179. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 180. UNITED STATES ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 181. UNITED STATES ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 182. CHINA ERUCAMIDE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 183. CHINA ERUCAMIDE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. CHINA ERUCAMIDE MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 185. CHINA ERUCAMIDE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 186. CHINA ERUCAMIDE MARKET SIZE, BY PACKAGING FILMS, 2018-2032 (USD MILLION)
  • TABLE 187. CHINA ERUCAMIDE MARKET SIZE, BY END USE INDUSTRY, 2018-2032 (USD MILLION)
  • TABLE 188. CHINA ERUCAMIDE MARKET SIZE, BY PACKAGING, 2018-2032 (USD MILLION)